XLO vs INMB
Comparison between Xilio Therapeutics Inc (XLO, Company) and INmune Bio Inc (INMB, Company).
Both XLO and INMB are from the Healthcare sector.
5-Year PerformanceINMB has outperformed XLO, delivering a return of -39.4% compared to -50.0%
XLO vs INMB - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
XLO vs INMB - Historical Returns
Returns include dividend reinvestment.
XLO vs INMB - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | XLO | INMB |
|---|---|---|
| 2026 | -11.63% | +11.69% |
| 2025 | -40.17% | -68.36% |
| 2024 | +66.09% | -58.38% |
| 2023 | -79.55% | +67.81% |
| 2022 | -83.24% | -40.69% |
| 2021 | +0.00% | -42.24% |
| 2020 | N/A | +179.86% |
| 2019 | N/A | -27.41% |
XLO vs INMB Drawdown Comparison
The maximum drawdown for XLO was -98.01%, occurring on Dec 20, 2023. This drawdown has not yet recovered.
The maximum drawdown for INMB was -95.98%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The current XLO drawdown is -97.64%. The current INMB drawdown is -93.82%.
| Rank | XLO | INMB |
|---|---|---|
| #1 | -98.01% Nov 16, 2021 - Dec 20, 2023 | -95.98% Sep 7, 2021 - Mar 27, 2026 |
| #2 | -15.07% Nov 2, 2021 - Nov 4, 2021 | -79.91% May 9, 2019 - Jul 14, 2020 |
| #3 | -7.66% Nov 4, 2021 - Nov 8, 2021 | -65.40% Jan 19, 2021 - Sep 7, 2021 |
| #4 | -6.89% Nov 8, 2021 - Nov 16, 2021 | -52.32% Jul 14, 2020 - Dec 31, 2020 |
| #5 | -2.19% Oct 26, 2021 - Oct 29, 2021 | -13.66% Feb 22, 2019 - Apr 8, 2019 |
| #6 | N/A | -9.29% Feb 4, 2019 - Feb 22, 2019 |
| #7 | N/A | -8.60% Apr 10, 2019 - Apr 22, 2019 |
| #8 | N/A | -5.83% Jan 6, 2021 - Jan 11, 2021 |
| #9 | N/A | -4.14% Apr 22, 2019 - May 1, 2019 |
| #10 | N/A | -4.11% May 2, 2019 - May 9, 2019 |
| #11 | N/A | -0.40% Jan 14, 2021 - Jan 19, 2021 |
| #12 | N/A | -0.23% Jan 11, 2021 - Jan 13, 2021 |
Correlation
Correlation between XLO and INMB is 0.53 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks